Imaging MS in Toxicology: An Investigation of Juvenile Rat Nephrotoxicity Associated with Dabrafenib Administration

Dabrafenib Therapy for Advanced Melanoma

(2014) Van Anh Trinh et al.   ANNALS OF PHARMACOTHERAPY

Growth in children with chronic kidney disease

(2014) Elizabeth G. Ingulli et al.   CURRENT OPINION IN PEDIATRICS

A Mimetic Tissue Model for the Quantification of Drug Distributions by MALDI Imaging Mass Spectrometry

(2013) M. Reid Groseclose et al.   ANALYTICAL CHEMISTRY

Drug safety testing paradigm, current progress and future challenges: an overview

(2013) Varun Ahuja et al.   JOURNAL OF APPLIED TOXICOLOGY

Molecular mechanisms of crystal-related kidney inflammation and injury. Implications for cholesterol embolism, crystalline nephropathies and kidney stone disease

(2013) S. R. Mulay et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Mass spectrometry imaging for drug distribution studies

(2012) Brendan Prideaux et al.   Journal of Proteomics

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

(2012) Axel Hauschild et al.   LANCET

Proliferative and Nonproliferative Lesions of the Rat and Mouse Urinary System

(2012) Kendall S. Frazier et al.   TOXICOLOGIC PATHOLOGY

Mimicking the Initial Development of Calcium Urolithiasis by Screening Calcium Oxalate and Calcium Phosphate Phases in Various Urinelike Solutions, Time Points, and pH Values at 37 °C

(2011) Tu Lee et al.   CRYSTAL GROWTH & DESIGN

Mass spectrometry imaging for drugs and metabolites

(2011) Tyler Greer et al.   Journal of Proteomics

MALDI imaging mass spectrometry: bridging biology and chemistry in drug development

(2011) Stephen Castellino et al.   Bioanalysis

Renal toxicity of therapeutic drugs

(2009) R John et al.   JOURNAL OF CLINICAL PATHOLOGY

Drug-induced crystal nephropathy: an update

(2008) Sri G Yarlagadda et al.   Expert Opinion On Drug Safety

Recent advances in the pathophysiology of nephrolithiasis

(2008) Khashayar Sakhaee   KIDNEY INTERNATIONAL